Transient hyperphosphatasemia in pediatric renal transplant patients--is there a need for concern and when?
Language English Country Denmark Media print-electronic
Document type Case Reports, Journal Article
PubMed
20819182
DOI
10.1111/j.1399-3046.2010.01379.x
PII: PTR1379
Knihovny.cz E-resources
- MeSH
- Alkaline Phosphatase blood MeSH
- Biopsy MeSH
- Child MeSH
- Hyperphosphatemia etiology therapy MeSH
- Bone and Bones pathology MeSH
- Humans MeSH
- Nephrotic Syndrome therapy MeSH
- Child, Preschool MeSH
- Protein Isoforms MeSH
- Renal Insufficiency therapy MeSH
- Radiography MeSH
- Kidney Transplantation methods MeSH
- Treatment Outcome MeSH
- Wrist diagnostic imaging MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Names of Substances
- Alkaline Phosphatase MeSH
- Protein Isoforms MeSH
TH of infancy and early childhood is characterized by transiently increased S-ALP, predominantly its bone or liver isoforms. There are neither signs of metabolic bone disease or hepatopathy corresponding to the increased S-ALP, nor a common underlying/triggering disease. TH may also occur in children post-renal Tx, which may raise significant concerns and anxiety. We describe four patients aged 2.8-7 yr in whom the TH occurred at 11-34 (median = 28) months after Tx and lasted from 40 to 105 (median = 63) days. No obvious cause/trigger of TH could be found; the clinical status and bone turnover were not altered. In cases of TH post-Tx, we recommend the evaluation of basic biochemical indices and wrist X-ray. If these results are normal, TH is most likely the diagnosis and the S-ALP can be monitored over the next three months without further testing. In patients with persisting TH for more than three months and/or in children with pre-existing or suspected metabolic bone disease, further evaluation may be indicated. In conclusion, TH is a benign disorder in patients post-Tx. Detailed investigation including bone biopsy is only indicated in patients with persisting TH.
References provided by Crossref.org
Normal bone turnover in transient hyperphosphatasemia